| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 05/10/2005 | US6890902 Cytotoxic modified lactoferrin peptides |
| 05/10/2005 | US6890899 A lipolytic or lipid mobilising factor (LMF) produced by the cachexia-inducing murine tumor MAC16; weight reduction or controlling obesity; administering a Zn-alpha 2-glycoprotein |
| 05/10/2005 | US6890765 Particles for immunoassays and methods for treating the same |
| 05/10/2005 | US6890565 Extracting coagulant protein derivatives from seeds of trees within the family Moringaceae especially those of Moringa oleifera Lam (syns Moringa pterygosperma Gaertn.) |
| 05/10/2005 | US6890512 Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 05/10/2005 | US6889727 Apparatus and method for the preparation of experiments using proteins contained within gels |
| 05/06/2005 | WO2005040338A2 Constrained alkaloid immunogens and antibodies and uses thereof |
| 05/06/2005 | WO2005040214A1 Virally-safe factor viii with a low content of higher multimers |
| 05/06/2005 | WO2005040197A1 Compositions, methods and kits for biarsenical fluorophore labeling |
| 05/06/2005 | WO2005014848A3 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES |
| 05/06/2005 | WO2004112727A3 Aav virions with decreased immunoreactivity and uses therefor |
| 05/06/2005 | WO2004094644A3 Vibrio cholerae proteins expressed during infection |
| 05/06/2005 | CA2543095A1 Virally-safe factor viii with a low content of higher multimers |
| 05/05/2005 | US20050096456 Compounds comprising pseudo-amino acids |
| 05/05/2005 | US20050096271 Fusion of polypeptides and immunoglobulin protein; immunotherapy ; antiallergens; antiarthritic agents; anticancer agents; antiinflammatory agents |
| 05/05/2005 | US20050095726 Novel high protein tortillas |
| 05/05/2005 | US20050095725 Enrichment of phosphate peptides for proteomic analysis |
| 05/05/2005 | US20050095661 determining a mass fingerprint from digests of polypeptides capped with lysine reactive agent comprising a hindered Michael reagent |
| 05/05/2005 | US20050095652 Solid support comprising immobilized biopolymers for use as assay in monitoring receptor ligand interaction; drug screening; antibodiy sensitivity |
| 05/05/2005 | US20050095647 Enrichment and tagging of glycosylated proteins |
| 05/05/2005 | US20050095638 Kit comprised peptide nucleic acid array for identifying sequences associated with preferential receptor/ligand binding |
| 05/05/2005 | US20050095201 Protein or peptide containing asparagyl-4-aminobutane and/or glutamyl-4-aminobutane residues; diagnostic magnetic resonance imaging |
| 05/05/2005 | US20050095198 Annexin derivatives with endogenous chelation sites |
| 05/04/2005 | EP1527345A2 Method for isolating atp binding proteins by means of immobilized protein inhibitors |
| 05/04/2005 | EP1527081A1 Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer |
| 05/04/2005 | EP0804734B1 Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood |
| 05/04/2005 | CN1612896A Peptide purification by means of metal ion affinity chromatography |
| 05/04/2005 | CN1612895A Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours |
| 05/04/2005 | CN1612891A Process for producing modified peptide |
| 05/04/2005 | CN1611511A Bacillus subtilis antibacterial peptide separating and purifying method |
| 05/04/2005 | CN1611227A Egg white activity aspiration extraction and activity measuring technique |
| 05/04/2005 | CN1200001C Use of degrease filter plate in separating process of human blood albumin |
| 05/04/2005 | CN1199991C Cockroach polypeptide extracted from cockroach and extraction method thereof |
| 05/04/2005 | CN1199989C Method for purifying teicoplanin by analog moving bed chromospheric separation |
| 05/04/2005 | CN1199987C Basic monocyclic compounds having NK2 antagonist action, processes for their preparation and formulations containing them |
| 05/04/2005 | CN1199985C Process for preparing potein molecule imprinted polymer and its application in biological engineering |
| 05/03/2005 | US6887976 Improved mammalian safety profile; glycopeptide phosphonate derivatives of invention unexpectedly exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammal; antibacterial agents |
| 05/03/2005 | US6887682 Chaperonin and osmolyte protein folding and related screening methods |
| 05/03/2005 | US6887670 For drug screening; solid phase synthesis; fusion proteins; genetic engineering |
| 05/03/2005 | US6887665 Forming a surface comprising photosensitive compound or group, an autocatalytic compound or group, compound capable of introducing latency irradiating at least a part of surface to remove protective group |
| 05/03/2005 | US6887659 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 05/03/2005 | US6887377 Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications |
| 05/03/2005 | CA2128215C Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 04/28/2005 | WO2005038460A2 Site-specific labeling of affinity tags in fusion proteins |
| 04/28/2005 | WO2005037869A2 Method of reducing leachate from protein a affinity media |
| 04/28/2005 | WO2005013889A3 Truncated fragments of alpha-synuclein in lewy body disease |
| 04/28/2005 | WO2005010165A3 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 04/28/2005 | WO2004112820A3 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| 04/28/2005 | WO2004110390A3 Anti-cd74 immunoconjugates and methods |
| 04/28/2005 | WO2004099379A3 Use of jag2 expression in diagnosis of plasma cell disorders |
| 04/28/2005 | WO2004075988A3 Methods of immunomodulation in animals |
| 04/28/2005 | WO2004011486A8 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |
| 04/28/2005 | US20050090651 Polymeric compounds |
| 04/28/2005 | US20050089952 Repeated filtration, diafiltration, ultrafiltration, permeation |
| 04/28/2005 | US20050089951 Method for labeled amidation of biological molecule and method for analyzing biological molecule |
| 04/28/2005 | US20050087445 Method and device for separation of charged molecules by solution isoelectric focusing |
| 04/28/2005 | US20050086822 High throughput isolation of biological compounds |
| 04/28/2005 | CA2542639A1 Novel heat shock protein 20-related polypeptides and uses therefor |
| 04/27/2005 | EP1525483A2 Differential labeling for quantitative analysis of complex protein mixtures by trifunctional synthetic peptide based reagents with iodacetamido groups |
| 04/27/2005 | EP1525313A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 04/27/2005 | EP1525266A1 Site-specific labelling of proteins using cyanine dye reporters |
| 04/27/2005 | EP1525046A1 Coated hydrophilic membranes for electrophoresis applications |
| 04/27/2005 | EP1474511B1 Separating method and an apparatus performing such a method |
| 04/27/2005 | EP1127063A4 Methods of purifying recombinant human erythropoietin from cell culture supernatants |
| 04/27/2005 | EP0966482B1 Crystallisation of proteins |
| 04/27/2005 | CN1609122A New method of preparing silk protein powder |
| 04/27/2005 | CN1198843C Method for chromatographically purifying insulins |
| 04/27/2005 | CN1198837C Purification of tissue plasminogen activator (tPA) |
| 04/26/2005 | US6884774 Cyclic hexapeptide derivatives |
| 04/26/2005 | CA2262215C Discrete quantitative structure activity relationships |
| 04/21/2005 | WO2005035565A1 Il-21 derivatives |
| 04/21/2005 | WO2005035553A2 Conjugation of peptides |
| 04/21/2005 | WO2005035552A2 Transducing combinatorial peptide library |
| 04/21/2005 | WO2005035092A1 Methods and kits for purifying his-tagged proteins |
| 04/21/2005 | WO2005034988A1 Long-acting molecules in sustained release formulations |
| 04/21/2005 | WO2005034853A2 Uses of interferons with altered spatial structure |
| 04/21/2005 | WO2004113924A3 Method and system for generating and capturing peptides on a target surface |
| 04/21/2005 | WO2004087883A3 lovE VARIANT REGULATOR MOLECULES |
| 04/21/2005 | WO2004072256A3 Variants of cytochrome c and methods of diagnostics of thrombocytopenia |
| 04/21/2005 | WO2004052273A3 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 04/21/2005 | US20050085631 Process for decreasing aggregate levels of pegylated protein |
| 04/21/2005 | US20050085624 Method and device |
| 04/21/2005 | US20050085622 Method for modifying protein or peptide C-terminal |
| 04/21/2005 | US20050085423 Administering an amide ciompound ; analgesics; antiinflamamtory agents |
| 04/21/2005 | US20050084927 Modified by immobilizing with disulfide-containing compound; mass spectrometry; solid phase synthesis |
| 04/21/2005 | US20050084902 Peptide-immobilized substrate and method for measuring target protein |
| 04/21/2005 | CA2542179A1 Il-21 derivatives |
| 04/21/2005 | CA2536066A1 Methods and kits for purifying his-tagged proteins |
| 04/21/2005 | CA2535982A1 Uses of interferons with altered spatial structure |
| 04/20/2005 | EP1524695A2 Affinity based self-assembly systems and devices for photonic and electronic applications |
| 04/20/2005 | EP1355920A4 Extractive purification of lipopeptide antibiotics |
| 04/20/2005 | EP1189926B1 Rapid dehydration of proteins |
| 04/20/2005 | EP1175505A4 Combinatorial chemical library supports having indicia at coding positions and methods of use |
| 04/20/2005 | EP1113817B1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 04/20/2005 | EP1049481B1 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 04/20/2005 | CN1608202A Method of electrophoresing protein |
| 04/20/2005 | CN1608077A Method for renaturating proteins |
| 04/20/2005 | CN1197946C Granule with hydrated barrier material |
| 04/20/2005 | CN1197876C Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 04/20/2005 | CN1197875C Process for purifying hematoglobin |